Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what estimate he has made of the effect on survival rates in kidney patients and on the Domain 1 outcomes of the NHS Outcomes Framework of transplants unsuccessful because of the lack of availability of immunosuppression treatments that the patient can tolerate, following the recommendation from the National Institute for Health and Care Excellence (review of TA 85) [ID456] to restrict access to such agents.

We have made no such assessment.

The National Institute for Health and Care Excellence (NICE) has not yet published its final updated guidance on the use of immunosuppressive therapy for kidney transplant in adults (review of TA85) or on the use of immunosuppressive therapy for kidney transplant in children and young people (review of TA99). NICE is developing resource impact reports to support implementation of its guidance which will be published alongside its final technology appraisal guidance.